Hinova Pharmaceuticals Inc. A (688302) — Working Capital to Net Assets Ratio
Hinova Pharmaceuticals Inc. A (688302) has a Working Capital to Net Assets ratio of 77.3% as of June 2025. Working capital of CN¥879.45 Million (current assets of CN¥1.01 Billion minus current liabilities of CN¥134.32 Million) is measured against net assets of CN¥1.14 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Hinova Pharmaceuticals Inc. A (688302) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Hinova Pharmaceuticals Inc. A Working Capital to Net Assets (2019–2024)
This chart shows how Hinova Pharmaceuticals Inc. A's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 77.3%, reflecting working capital of CN¥879.45 Million against net assets of CN¥1.14 Billion CNY. Check tangible net worth ratio of Hinova Pharmaceuticals Inc. A to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Hinova Pharmaceuticals Inc. A (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Hinova Pharmaceuticals Inc. A from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Hinova Pharmaceuticals Inc. A stock valuation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 61.9% | CN¥738.59 Million | CN¥1.19 Billion | CN¥885.54 Million | CN¥146.95 Million | ▼ -14.2 pp |
| 2023 | 76.1% | CN¥1.04 Billion | CN¥1.37 Billion | CN¥1.15 Billion | CN¥106.84 Million | ▼ -16.8 pp |
| 2022 | 92.9% | CN¥1.47 Billion | CN¥1.59 Billion | CN¥1.61 Billion | CN¥138.27 Million | ▼ -3.9 pp |
| 2021 | 96.8% | CN¥763.91 Million | CN¥788.76 Million | CN¥955.24 Million | CN¥191.33 Million | ▼ -2.8 pp |
| 2020 | 99.7% | CN¥982.80 Million | CN¥986.15 Million | CN¥1.18 Billion | CN¥199.52 Million | ▼ -13.8 pp |
| 2019 | 113.4% | CN¥-40.60 Million | CN¥-35.78 Million | CN¥39.90 Million | CN¥80.50 Million | — |